Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia

Leukemia. 2005 Feb;19(2):286-7. doi: 10.1038/sj.leu.2403600.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Blast Crisis / blood
  • Chronic Disease
  • Eosinophilia / blood
  • Eosinophilia / complications*
  • Eosinophilia / pathology
  • Humans
  • Leukocyte Count
  • Male
  • Myeloproliferative Disorders / blood
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / pathology
  • Oncogene Proteins, Fusion / genetics
  • Platelet Count
  • Receptor, Platelet-Derived Growth Factor alpha / genetics*
  • mRNA Cleavage and Polyadenylation Factors / genetics*

Substances

  • Oncogene Proteins, Fusion
  • mRNA Cleavage and Polyadenylation Factors
  • FIP1L1-PDGFRA fusion protein, human
  • Receptor, Platelet-Derived Growth Factor alpha